Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2022 09:00 ET | Source: Blue Note Therapeutics

Blue Note Therapeutics Enters Licensing Agreement With University of Sydney for ConquerFear, a Cancer Survivorship Intervention

SAN FRANCISCO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics, a prescription digital therapeutics company dedicated to easing the burden of cancer and improving outcomes, today announced...